Alzheimer's Drug Discovery Foundation (ADDF)
The ADDF accelerates the discovery of drugs to prevent and treat Alzheimer's disease through research funding and portfolio management.
Detaljerad introduktion
The Alzheimer's Drug Discovery Foundation (ADDF) is dedicated to advancing the discovery of drugs to prevent and treat Alzheimer's disease. ADDF funds research programs focused on drug development, biomarkers, and prevention strategies. In 2024, ADDF catalyzed significant breakthroughs, including major investments in scalable blood tests and the cataloging of Alzheimer's biomarkers. The foundation also marked the 10th anniversary of the Goodes Prize and celebrated the FDA approval of Kisunla (Donanemab). ADDF's diverse portfolio is one of the largest worldwide, emphasizing lifestyle interventions and innovative diagnostics.
MerForskning
Max Planck Institute for Human Cognitive and Brain Sciences
The Max Planck Institute for Human Cognitive and Brain Sciences is a leading research institution focusing on understanding the human brain, cognition, and behavior through interdisciplinary research and advanced technologies.
ResearchGate
ResearchGate is a website that requires verification of your humanity before allowing access. This process may take a few seconds as the site reviews the security of your connection.
The American Psychological Association’s Divisions
The American Psychological Association (APA) has various divisions that focus on different areas of psychology.